ICAD Icad Inc
Price (delayed)
$1.95
Market cap
$53.36M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.21
Enterprise value
$36.52M
iCAD Inc., headquartered in Nashua, New Hampshire, is a medical-device manufacturer. iCAD makes cancer detection and radiation therapy devices. iCAD offers computer aided detection and workflow solutions to support detection
Highlights
The debt has decreased by 21% YoY and by 13% from the previous quarter
ICAD's revenue is up by 13% YoY and by 3.5% QoQ
The net income has plunged by 107% from the previous quarter and by 16% YoY
The company's EPS has shrunk by 91% QoQ and by 11% YoY
Key stats
What are the main financial stats of ICAD
Market
Valuations
Earnings
Shares outstanding
27.37M
Market cap
$53.36M
Enterprise value
$36.52M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.8
Price to sales (P/S)
2.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.86
Revenue
$19.61M
Gross profit
$16.64M
Operating income
-$6.27M
Net income
-$5.62M
EBIT
-$5.51M
EBITDA
-$4.78M
Free cash flow
-$4.46M
Per share
Balance sheet
Liquidity
EPS
-$0.21
EPS diluted
-$0.21
Free cash flow per share
-$0.17
Book value per share
$1.08
Revenue per share
$0.74
TBVPS
$1.1
Total assets
$37.54M
Total liabilities
$8.86M
Debt
$362,000
Equity
$28.68M
Working capital
$18.87M
Debt to equity
0.01
Current ratio
3.5
Quick ratio
3.23
Net debt/EBITDA
3.52
Margins
Efficiency
Dividend
EBITDA margin
-24.4%
Gross margin
84.8%
Net margin
-28.6%
Operating margin
-32%
Return on assets
-14.6%
Return on equity
-18.5%
Return on invested capital
-119.6%
Return on capital employed
-18.4%
Return on sales
-28.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ICAD stock price
How has the Icad stock price performed over time
Intraday
-1.52%
1 week
-11.36%
1 month
-19.09%
1 year
21.88%
YTD
6.56%
QTD
-5.34%
Financial performance
How have Icad's revenue and profit performed over time
Revenue
$19.61M
Gross profit
$16.64M
Operating income
-$6.27M
Net income
-$5.62M
Gross margin
84.8%
Net margin
-28.6%
The net income has plunged by 107% from the previous quarter and by 16% YoY
The net margin has plunged by 100% from the previous quarter and by 2.1% YoY
The operating margin has increased by 28% year-on-year
Icad's operating income has increased by 18% YoY but it has decreased by 2.4% from the previous quarter
Growth
What is Icad's growth rate over time
Valuation
What is Icad stock price valuation
P/E
N/A
P/B
1.8
P/S
2.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.86
The company's EPS has shrunk by 91% QoQ and by 11% YoY
ICAD's price to book (P/B) is 52% lower than its 5-year quarterly average of 3.8 but 31% higher than its last 4 quarters average of 1.4
The equity has contracted by 14% YoY and by 2.3% from the previous quarter
ICAD's P/S is 47% below its 5-year quarterly average of 5.0 but 21% above its last 4 quarters average of 2.2
ICAD's revenue is up by 13% YoY and by 3.5% QoQ
Efficiency
How efficient is Icad business performance
The ROE has plunged by 115% from the previous quarter and by 21% YoY
Icad's return on assets has shrunk by 112% QoQ and by 35% YoY
ICAD's return on invested capital has dropped by 109% since the previous quarter and by 86% year-on-year
The company's return on sales has shrunk by 99% QoQ
Dividends
What is ICAD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ICAD.
Financial health
How did Icad financials performed over time
Icad's quick ratio has decreased by 22% YoY and by 13% from the previous quarter
The current ratio has contracted by 20% YoY and by 13% from the previous quarter
The debt is 99% less than the equity
The debt has decreased by 21% YoY and by 13% from the previous quarter
The equity has contracted by 14% YoY and by 2.3% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.